Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLCShugeng Gao, Jie He, Ning Li et al.|Journal of Thoracic Oncology|2020Cited by 415
Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localizationFenglong Bie, Shugeng Gao, Ruochuan Zang et al.|Nature Communications|2023Cited by 70
Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinomaJianchun Duan, Zhijie Wang|Cell Reports Medicine|2023Cited by 28
Detection of <i>MET</i> Polysomy by Next-generation Sequencing and Its Clinical Relevance for <i>MET</i> InhibitorsBoyang Sun, Zhijie Wang|Cancer Research Communications|2023Cited by 13
Two-year follow-up of single PD-1 blockade in neoadjuvant resectable NSCLC.Shugeng Gao, Jie He, Ning Li et al.|Journal of Clinical Oncology|2021Cited by 5